GROUND REPORTS

Elusive And Expensive: COVID-19 Life Saving Drugs

Covid-19 life-saving drugs Tocilizumab and Remdesivir are not easily available for relatives of patients who might need them.

By - BOOM | 11 July 2020 11:29 PM IST

How is a shortage of life-saving drugs against COVID-19 like Tocilizumab and Remdesivir pushing families of coronavirus patients to desperation? Relatives of COVID-19 positive patients say they are charged between Rs 31,500 - 72,000 to source a 400 mg vial of Tocilizumab on the black market.

Related Stories

Surviving the Divide: Inter-Community Families Amidst Manipur Violence

Locals Speak Out on Nuh Clashes | Haryana Violence Ground Report

Indian Rappers Tackle Caste & Class: Rap's Social Impact

G20 Demolitions Leave Delhi's Homeless Displaced

S. S. Gautam: The Dalit Publisher Amplifying Marginalized Voices